|
corticotropin-releasing factor receptor, subtype 1 (CRFR1) [GE]
Corticotropin-releasing factor receptor, subtype
1 (CRFR1)-deficient mice displayed increased exploratory behavior
in the elevated Plus-Maze and the Black and White test box, both
models of anxiety. These results suggested that the CRFR1
gene plays a role in anxiety. The CRFR1 deficient mice
also were impaired in spatial recognition memory, indicating
that this gene is involved in cognitive biological processes,
as well. Contarino et al., Brain Res., 835:1-9, 1999.
dopamine receptor, type 2 (DR2) [HGL]
A significantly increased incidence of migraine
with aura (MWA), major depression, and generalized anxiety disorder
(GAD), panic attacks, and phobia was observed in individuals with
a DR2 allele NcoI C/C genotype compared with individuals with a
DR2 NcoI T allele. Peroutka et al., Mol. Med., 4:14-21, 1998.
gamma-aminobutyric acid (GABA) receptor, type A [GE]
5-HTR1A "knock-out" mice displayed
reduced binding to the GABA receptor, type A (GABA-A), impaired
GABAergic transmission, and benzodiazepine-resistant anxiety. These
results suggest that a deficit in the 5-HTR1A leads to abnormalities
in the GABAergic pathways which in turn results in benzodiazepine-resistant
anxiety. Sibille et al., J. Neurosci., 20:2758-2765, 2000.
See entry under "serotonin receptor, subtype 1A (5-HTR1A)."
gamma-aminobutyric acid (GABA) receptor, type A, subtype alpha-2
[GE]
Two transgenic mouse cell lines were generated
in which the alpha-2 and alpha-3 GABA-A receptors were rendered
insensitive to diazepam by a point mutation in the drug binding
site. Alpha-2 receptors are present in the limbic system,
cerebral cortex, hippocampus, and striatum, whereas alpha-3 receptors
are expressed in the brainstem reticular formation, the basal forebrain,
and the reticular nucleus of the thalamus. Both lines of
transgenic mice displayed a normal response to the sedative, motor-impairing,
and anticonvulsant activities of diazepam, but only alpha-2 mice
did not show the behavioral disinhibition by diazepam observed
in normal and alpha-3 mice. These results indicate that the
anxiolytic activity of diazepam is mediated by alpha-2 GABA-A receptors,
suggesting their role, and associated pathways in the limbic system,
cerebral cortex, and hippocampus, in anxiety-related disorders. Low
et al., Science, 290:131-134, 2000.
glutamic acid decarboxylase, 65 kDa isoform (GAD65) [GE]
Glutamic acid decarboxylase (GAD) is involved
in the synthesis of GABA, a neurotransmitter in the CNS. Mice
with an inactivated GAD gene showed abnormal behaviors, including
increased anxiety-like behavior and reduced intermale aggression. Stork
et al., Brain Res., 865:45-58, 2000. See, also entry under
Agreeableness.
protein kinase C, gamma isoform (PKC-gamma) [GE]
Protein kinases (PKC) are enzymes that phosphorylate
proteins. PKCs are part of the signal transduction pathway. For
instance, stimulation of a receptor by its cognate hormone or neurotransmitter
can lead to the production of cAMP, which in turn activates PKC. Activated
PKC phosphorylates various substrates in the pathway, triggering
various cellular responses, including, secretion, changes in membrane
permeability, and gene activation. PKC-gamma is involved
in 5-HT2 and GABA-A signalling (see also, entries under "gamma-aminobutyric
acid (GABA) receptor, type A"). To study the role of the
gamma isoform of PKC in behavior, mice completely lacking the gene
were engineered. Null mutant mice (deficient in both copies
of the gene) displayed a decrease in baseline anxiety-related behaviors
in several different test. Locomotor activity was normal
indicating that the reduced anxiety was not due to baselibne differences
in it. Bowers et al., Behav. Genet., 30:111-121, 2000.
regulator of G-protein signaling-2 (rgs2) [GE]
Regulator of G-protein signaling-2 (rgs2) is
a member of a family of genes which accelerate the GTPase activity
of G-proteins, components of signal transduction pathways. They
contain a conserved RGS domain of about 120 amino acids. rgs2
is up-regulated in the central nervous system after stimuli which
evok long-term neuronal plasticity and also in activated T-cells. To
investigate its in vivo role, rgs2-deficient mice were generated. The
rgs2 deficieny had no apparent effect on motor responses, exploratory
behavior, spatial learning, or memory. However, mice lacking
the rgs2 gene completely (rgs2-/rgs2-) showed reduced male aggression
when compared to heterozygous (rgs2-/rgs+) littermates. The
aggressive response of female mice deficient in rgs2 was normal. In
addition to aggression, rgs2-deficient mice showed increased anxiety
as compared to heterozygous littermates (data comparing males and
females in the anxiety test were not presented.) Differences
in the CA1 hippocampal neursons were observed in rgs-deficient
mice as compared to controls. Oliveira-dos-Santos et al.,
Proc. Natl. Acad. Sci., 97:12272-12277, 2000. See, also entry
under Agreeableness.
serotonin receptor, subtype 1A (5-HTR1A) [GE]
Transgenic mice were created by gene-targeting
strategy which lack a functional type 1A serotonin receptor (5-HTR1A). Homozygous
mutants displayed a consistent pattern of responsies indicative
of increased anxiety levels in open-field, elevated-zero maze,
and novel-object assays. Heisler et al., Proc. Natl. Acad.
Sci., 95: 15049-54, 1998. Similar results in Parks et al.,
Proc. Natl. Acad., 95:10734-9, 1998. 5-HTR1A "knock-out" mice
also showed benzodiazepine-resistant anxiety. Binding to
the GABA(A) receptor was reduced and GABAergic transmission was
impaired in the mutant mice. Sibille et al., J. Neurosci.,
20:2758-2765, 2000.
serotonin receptor, subtype 1B (5-HTR1B) [GE]
Mice deficient in subtype 1B serotonin receptor
show reduced anxiety and are hyperactive throughout their life. Pups
lacking 5-HTR-1B were more hyperactive than wild-type pups. 5-HTR-1B
deficient mothers spent 20% more time out of the nest than wild-type
mothers. They showed elevated hyperactivity, rearing and
climbing to the edge of the cage more than the normal control mothers. Brunner
et al., Behav. Neurosci., 113:587-601, 1999.
serotonin transporter gene (5-HTT or SERT)+ [HGL]
A polymorphism in the promoter region of the
5-HTT gene was detected in humans. A long and short version
of the gene was identified, depending on whether it contained a
DNA insertion. The short variant of the polymorphism results
in decreased expression of 5-HTT and a decrease in serotonin uptake. This
polymorphism was associated with increased increased anxiety in
sample of human subjects. Lesch et al., Science, 274(5292):1526-1531,
1996. See, also, Murakami et al., J. Human Genetics, 1:15-17,
1999. These results have not been replicated by others.
Jorm et al., Mol. Psychiatry, 3:449-451, 1998; Ohara et al., Biol.
Psychiatry, 44:550-554, 1998.
dopamine receptor, type 1 [GE]
The cholera toxin gene was placed under the
control of the dopamine receptor, type 1 (DR1), promoter. Cholera
toxin gene expression was restricted to CNS neurons. Variations
in the regional expression of the gene was observed in different
transgenic lines. Expression of the cholera toxin gene
resulted in stimulation of the G-protein signal transduction pathway,
including cAMP synthesis. In one transgenic line studied,
in which expression was observed in the piriform cortex layer II,
the somatosensory cortex, and the amygdala, a constellation
of behaviors were observed that strongly resembled compulsive disorders,
such as obsessive- compulsive disorder (OCD). These
abnormal behaviors included repetitive non-aggressive biting and
leaping. Campbell et al., J. Neurosci., 19:5044-5043, 1999.
serotonin transporter gene (5-HTT or SERT) [HGL]
The "L" SLC6A4 allele of the 5-HTT
gene was associated with obsessive-compulsive disorder (OCD). McDougle
et al., Mol. Psychiatry, 3: 270-273, 1998.
serotonin transporter (5-HTT or SERT)*
[HGL]
No association between a functional polymorphism
in the promoter of the 5-HTT gene and panic disorder. Hamilton
et al., Psychiatr. Genet., 9:1-6, 1999.
|